|
Volumn 37, Issue 1, 2016, Pages 1-3
|
Curcumin as an Adjunct Drug for Infectious Diseases
|
Author keywords
clinical trials; curcumin; drugs; infectious diseases; malaria
|
Indexed keywords
AMOXICILLIN;
AMPICILLIN;
ARTEETHER;
BENZNIDAZOLE;
CIPROFLOXACIN;
CLARITHROMYCIN;
CURCUMIN;
NIFURTIMOX;
NORFLOXACIN;
OXACILLIN;
ANTIINFECTIVE AGENT;
IMMUNOLOGIC FACTOR;
IMMUNOLOGICAL ADJUVANT;
ANTIBIOTIC RESISTANCE;
BACTERIAL COUNT;
CHAGAS DISEASE;
CLINICAL TRIAL (TOPIC);
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG RESPONSE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
IMMUNOMODULATION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PLASMODIUM BERGHEI;
PLASMODIUM BERGHEI INFECTION;
PRIORITY JOURNAL;
PUBLIC HEALTH;
REVIEW;
SURVIVAL RATE;
TH2 CELL;
TREATMENT DURATION;
TRYPANOSOMA CRUZI;
ANIMAL;
INFECTION;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
ANTI-INFECTIVE AGENTS;
CLINICAL TRIALS AS TOPIC;
CURCUMIN;
HUMANS;
IMMUNOLOGIC FACTORS;
INFECTION;
|
EID: 84951292803
PISSN: 01656147
EISSN: 18733735
Source Type: Journal
DOI: 10.1016/j.tips.2015.09.007 Document Type: Short Survey |
Times cited : (27)
|
References (12)
|